PTU - Polskie Towarzystwo Urologiczne
list of articles:

TRANSURETHRAL ELECTRORESECTION OF TUMOURS INFILTRATING THE BLADDER
Article published in Urologia Polska 1990/43/1.

authors

Andrzej Prajsner, Adam Szkodny, Mirosław Salamon, Wiesław Duda
Z I Katedry i Kliniki Urologii ¦l±skiej Akademii Medycznej im. L, Waryńskiego w Katowicach
Kierownik Kliniki: prof. zw. dr hab. n. med. A. Szkodny

summary

In the years 1982?1986 in the Department of Urology. Silesian Medical Acade­my in Katowice 591 transurethral resections were done in 426 cases of infiltrating bladder tumour. Information on the fates of the patients was obtained in 266 cases. Three-year survival rate was 20.3%. Recurrence and/or progression of the primary lesion was noted in all cases with T3 tumours and 60,4°/o of those with T2 tumours.

references

  1. 1. Barnes R. W., Bergmnan R. T., Hadley H. L., Love D.: Control of bladder
  2. tumors by endoscopis surgery. J.Urol., 1967, 97, 864. ? 2. Blandy J.P., England H.R.,
  3. Evans S. J. W.: T3 bladder cancer. The case for salvage cystectomy. Brit. J. Urol.,
  4. 1980, 52, 506. ? 3. Citrin D.L., Hogan T.F., Davis T. B.: A study of cyclophospha­
  5. mide, adriamycin, cis-platinum and methotrexate in advanced transitional cell
  6. carcinoma of the urinary tract. Cancer, 1983; 51, 1. ? 4. Corbusier A., Von den
  7. Bassche R., Wespes E., Regemorter G., Chulman C: Adjuwant chemotherapy in
  8. infiltrating urothelial tumours M-VAG. 8th Congress of EAV, London, 1988, Book
  9. of abstracts 97, 136. ? 5. Hall R. R., Roberts J. T., Powell P., Neal D. E., Hendrix G.,
  10. Marsh M.: Radical TUR with cisplatinum and methotrexate for T3 bladder can­
  11. cers. 8th Congress of EAU, London, 1988, Book of abstracts 97, 138. ? 6. Lutzeyer
  12. W., Rubben H., Dahm H.: Prognostic parameters in superficial bladder cancer: an
  13. analysis of 315 cases. J. Urol., 1982, 127, 250. ? 7. Marberger H., Marberger M.,
  14. Decristoforo A.: The current status of transurethral resection in the diagnosis and
  15. therapy of carcinoma of the urinary bladder. Int. Urol. Nephrol., 1972, 4, 1, 35. ?
  16. 8. Narayama A. S., Loenig S. A., Slyman D. J., Culp A.: Bladder cancer: factors
  17. affecting surrvival. J.Urol., 1983, 130, 56. ? 9. O'Flynn J.D., Smith J.M., Hanson
  18. T.: Transurethral resection for the assessement and treatment of vesical neoplasm.
  19. Eur. Urol., 1975, 1, 38. ? 10. Richie J. P., Skinner D. G., Kaufman J. J.: Radical
  20. cystectomy for carcinoma of the bladder: 16 years of experience. J.Urol., 1975, 113,
  21. 186.
  22. 11. Skinner D.G., Ttff J.P., Kaufman J.J.: High dose, short course preopera-
  23. tion radiation therapy and immediate single stage radical cystectomy with pelvic
  24. lymph node dissection in the management of bladder cancer. J. Urol., 1982.127, 671.?
  25. 12. Smith J. A., Regional lymph node metasteses from bladder cancer. J. Urol, 1981,
  26. 126, 591. ? 13. Vock P., Haertel M., Fucks W. A., Karrer P., Bishop M.C, Zingg
  27. J. J.: Computed tomography in staging of carcinoma of the urinary bladder. Brit.
  28. Urol. 1982, 54, 158. ? 14. Zingg E. J,, Wallace M. A.: Bladder cancer. Springer Ver-
  29. lag, Berling, Heidelberg, New York, Tokyo, 1985, 283.